Titan Bio-Tech Ltd.

BSE: TITANBIO524717ISIN INE150C01029

Commodities
Specialty Chemicals

BSE listing

Share price

₹410.65+6.05 (+1.50%)

as of 18 Sep 2026

52W high: ₹1,460.00
52W low: ₹202.05
Off 52W high: -71.87%
1M return: +3.02%
3M return: -5.40%
6M return: +3.56%
1Y return: -55.73%
20D avg volume: 29,489
50 DMA: ₹408.24
200 DMA: ₹599.40

Key ratios Consolidated

Market cap: ₹1,697 Cr
Current price: ₹410.65
52W high / low: ₹1,460.00 / ₹202.05
Face value: ₹2.00
P/E: 50.08
P/B: —
EPS (TTM): ₹8.20
Book value / share: —
ROE: —
ROCE: 20.80%
Operating margin: —
Net margin: —
Debt / equity: 0.02
Net debt: ₹2.19 Cr
Interest cover: 42.95
Dividend yield: 0.49%
Dividend / share (TTM): ₹2.00
Payout: 24.39%
Cash conversion cycle: 124.0 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	59.17	48.83	56.51	54.35	46.50	35.17	—
	1.81	2.11	1.26	1.32	0.72	1.38	—
	48.24	40.66	47.20	46.46	39.11	31.52	—
	29.93	25.91	27.28	27.43	18.55	17.30	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	8.70	9.44	8.53	7.38	7.01	6.94	—
	0.20	0.24	0.26	0.22	0.20	0.08	—
	1.37	1.30	1.27	1.21	1.15	0.84	—
	10.09	10.86	9.78	11.60	6.80	8.64	—
	12.73	10.28	10.56	9.22	8.11	5.03	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	12.73	10.28	10.56	9.22	8.11	5.03	—
	3.28	3.73	2.69	2.36	1.95	1.26	—
	10.86	6.73	8.53	7.76	6.86	4.05	—
	2.63	1.63	10.32	9.40	8.30	4.90	—
Key metrics
	14.30	11.82	12.09	10.65	9.46	5.95	—
	24.20%	24.20%	21.40%	19.60%	20.30%	16.90%	—
	18.40%	13.80%	15.10%	14.30%	14.80%	11.50%	—
	—	5.60%	—	5.50%	—	3.30%	—
	27.20%	38.80%	—	—	—	—	—
	58.30%	66.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	218.86	206.19	156.45	—
	6.50	5.41	3.91	—
	182.56	173.43	136.00	—
	110.55	99.16	75.48	—
	0.00	0.00	0.00	—
	34.05	32.36	26.38	—
	0.92	0.91	0.80	—
	5.15	4.93	4.17	—
	42.33	39.03	32.02	—
	42.79	38.17	24.37	—
	0.00	0.00	0.00	—
	42.79	38.17	24.37	—
	12.06	10.73	6.10	—
	33.88	29.89	21.53	—
	23.98	7.23	26.06	—
Key metrics
	48.86	44.01	29.34	—
	22.32%	21.30%	18.80%	—
	15.48%	14.50%	13.80%	—
	—	20.80%	16.00%	—
	—	31.80%	—	—
	—	38.80%	—	—
	—	21.11	10.73	—
	—	1.02	0.93	—
	—	0.02	0.01	—
	—	2.19	-3.03	—
	—	124.0	150.0	—
Balance sheet
	—	213.88	174.71	—
	—	85.24	79.04	—
	—	1.48	5.13	—
	—	22.83	18.82	—
	—	55.77	50.72	—
	—	—	3.87	—
	—	51.34	57.16	—
	—	8.54	5.22	—
	—	25.96	17.74	—
	—	3.67	2.10	—
	—	3.34	1.92	—
	—	0.33	0.18	—
	—	181.55	153.40	—
Cash flow
	—	30.42	20.12	—
	—	-34.41	-9.87	—
	—	0.34	-7.96	—
	—	9.31	9.39	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	59.17	48.83	56.51	54.35	46.50	35.17	—
	1.81	2.11	1.26	1.32	0.72	1.38	—
	48.24	40.66	47.20	46.46	39.11	31.52	—
	29.93	25.91	27.28	27.43	18.55	17.30	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	8.70	9.44	8.53	7.38	7.01	6.94	—
	0.20	0.24	0.26	0.22	0.20	0.08	—
	1.37	1.30	1.27	1.21	1.15	0.84	—
	10.09	10.86	9.78	11.60	6.80	8.64	—
	12.73	10.28	10.56	9.22	8.11	5.03	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	12.73	10.28	10.56	9.22	8.11	5.03	—
	3.28	3.73	2.69	2.36	1.95	1.26	—
	9.46	6.56	7.87	6.86	6.16	3.77	—
	2.29	1.59	9.52	8.30	7.46	4.56	—
Key metrics
	14.30	11.82	12.09	10.65	9.46	5.95	—
	24.20%	24.20%	21.40%	19.60%	20.30%	16.90%	—
	16.00%	13.40%	13.90%	12.60%	13.20%	10.70%	—
	—	5.90%	—	5.90%	—	3.30%	—
	27.20%	38.80%	—	—	—	—	—
	53.60%	74.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	218.86	206.19	156.45	—
	6.50	5.41	3.91	—
	182.56	173.43	136.00	—
	110.55	99.16	75.48	—
	0.00	0.00	0.00	—
	34.05	32.36	26.38	—
	0.92	0.91	0.80	—
	5.15	4.93	4.17	—
	42.33	39.03	32.02	—
	42.79	38.17	24.37	—
	0.00	0.00	0.00	—
	42.79	38.17	24.37	—
	12.06	10.73	6.10	—
	30.75	27.45	18.27	—
	21.70	6.64	22.11	—
Key metrics
	48.86	44.01	29.34	—
	22.32%	21.30%	18.80%	—
	14.05%	13.30%	11.70%	—
	—	22.10%	16.00%	—
	—	31.80%	—	—
	—	50.20%	—	—
	—	21.11	10.73	—
	—	1.11	1.10	—
	—	0.02	0.01	—
	—	2.19	-3.03	—
	—	124.0	150.0	—
Balance sheet
	—	203.18	174.71	—
	—	85.24	79.04	—
	—	1.48	5.13	—
	—	22.83	18.82	—
	—	55.77	50.72	—
	—	—	3.87	—
	—	51.34	57.16	—
	—	8.54	5.22	—
	—	25.96	17.74	—
	—	3.67	2.10	—
	—	3.34	1.92	—
	—	0.33	0.18	—
	—	170.84	153.40	—
Cash flow
	—	30.42	20.12	—
	—	-34.41	-9.87	—
	—	0.34	-7.96	—
	—	9.31	9.39	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 55.78%

Holder	Type	Holding	Previous	Change
Titan Securities Ltd	Promoter Group	33.59%	—	—
Investor Education And Protection Fund Author	Public	9.51%	—	—
Tanita Leasing & Finance Limited	Promoter Group	9.49%	—	—
Connoisseur Management Services Private Limit	Promoter Group	6.78%	—	—
Manish Goel	Public	2.80%	—	—
Titan Biotech Limited Unclaimed Suspense Dema	Public	2.36%	—	—
Suresh Chand Singla	Promoter	1.28%	—	—
Manju Singla	Promoter	0.86%	—	—
Madhu Gupta	Promoter	0.80%	—	—
Raja Singla	Promoter Group	0.74%	—	—
Supriya Singla	Promoter Group	0.66%	—	—
Udit Singla	Promoter Group	0.61%	—	—
Shivom Singla	Promoter Group	0.43%	—	—
Naresh Kumar Singla	Promoter	0.42%	—	—
Naresh Kumar Singla Huf	Promoter Group	0.12%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Notice of Loss of Share Certificate-Disclosure under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations, 201510 Sep 2026 · Company Update / Newspaper Publication
Newspaper Publication regarding Notice of 34th Annual General Meeting, E-Voting and other related information7 Sep 2026 · Company Update / Newspaper Publication
The Company has sent Letters to those members who have not registered their email address with the Company/RTA/ Depository providing a weblink including exact path of Website to access ....5 Sep 2026 · Company Update / General
Notice of 34th Annual General Meeting of the Company scheduled to be held on Tuesday, September 29, 2026 at 03:00 P.M.(IST) through VC/OAVM5 Sep 2026 · AGM/EGM / AGM
34th Annual Report of the Company for Financial Year 2025-265 Sep 2026 · Others / Reg. 34 (1) Annual Report
Newspaper advertisement regarding 34th Annual General Meeting of Titan Biotech Limited through VC/OAVM4 Sep 2026 · Company Update / Newspaper Publication
Intimation of record date for the purpose of Dividend to the members of the Company for FY 2025-26.3 Sep 2026 · Corp. Action / Record Date
The 34th Annual General Meeting of the Company scheduled to be held on September 29, 2026 through VC/ OAVM and the Company accordingly fixed Record Date, Book Closure Date and E-Voting Date3 Sep 2026 · AGM/EGM / AGM
Fixation of Annual General Meeting Date, Record Date, Book Closure date and dates for E-Voting3 Sep 2026 · Corp. Action / Book Closure
Recommended the Issuance of Bonus Issue, subject to shareholders approval and any other applicable regulatory and statutory approval, in the ratio of 1:4 .i.e. 1(one) new Fully paid up ....3 Sep 2026 · Corp. Action / Bonus
Recommended Issuance of Bonus Shares, subject to shareholders approval and any other applicable regulatory and statutory approval, in ratio of 1:4 i.e. 1(one) new fully paid up Equity Shares ....3 Sep 2026 · Board Meeting / Outcome of Board Meeting
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 ,inter alia, to consider and approve 1. the proposal of bonus issue, ....31 Aug 2026 · Board Meeting / Board Meeting
Closure of Trading Window31 Aug 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper publication of the Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 202614 Aug 2026 · Company Update / Newspaper Publication
Board Meeting Outcome For Unaudited Financial Results For Quarter Ended June 30, 202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
Unaudited Financial Results along with the limited review report from the statutory Auditor of the Company for the quarter ended June 202613 Aug 2026 · Result / Financial Results
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the standalone and consolidated ....5 Aug 2026 · Board Meeting / Board Meeting
Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 20186 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for loss of shares by shareholder which have already been transferred earlier to Investor Education Protection Fund.25 Jun 2026 · Company Update / Press Release / Media Release (Revised)
Closure of trading window23 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper publication of the Audited Financial Results (Standalone & Consolidated) for fourth quarter and year ended March 31, 20261 Jun 2026 · Company Update / Newspaper Publication
Intimation for re-appointment of Cost Auditor of the Company30 May 2026 · Company Update / General
The Board of Director of the Company has recommended a dividend of Rs. 0.50 paisa per Equity Share30 May 2026 · Corp. Action / Dividend
Audited Financial Results for March 31, 202630 May 2026 · Result / Financial Results
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors, at its meeting held today i.e. ....30 May 2026 · Board Meeting / Outcome of Board Meeting
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the audited financial results ....20 May 2026 · Board Meeting / Board Meeting
Second 100 days Campaign under Saksham Niveshak Yojna6 May 2026 · Company Update / General
Newspaper publication regarding special window for re-lodgement of transfer request and dematerialisation of physical shares.6 May 2026 · Company Update / Press Release / Media Release
Annual Secretarial Compliance Report for the financial year ending March 31, 20264 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....28 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Newspaper advertisement for Loss of Share Certificate23 Apr 2026 · Company Update / Press Release / Media Release
Newspaper advertisement for Loss of Share Certificate6 Apr 2026 · Company Update / Press Release / Media Release
Compliance Certificate under Regn 74(5) of SEBI (DP) Regulations, 20184 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window26 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation pertaining to credit confirmation of Equity Shares from the depositories regarding Sub-Division/Split of Equity Shares of the Company.27 Feb 2026 · Company Update / General
Please find attached herewith report for the period from 01.01.2026 to 06.01.2026 pertaining to re-lodgment of transfer of physical shares17 Feb 2026 · Company Update / General
Newspaper Publication of the unaudited financial Results (Standalone & Consolidated) for third quarter and nine months ended December, 202513 Feb 2026 · Company Update / Newspaper Publication
Unaudited Financial Results (Standalone & Consolidated) for the third quarter and Nine Months Ended December 31, 202512 Feb 2026 · Result / Financial Results
Outcome of the board meeting held on 12th February, 2026.12 Feb 2026 · Board Meeting / Outcome of Board Meeting
Activation of New ISIN for Sub-Division of Equity Shares of the Company.10 Feb 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.2/-	20 Feb 2026	20 Feb 2026	—
Final Dividend - Rs. - 2.0000	19 Sep 2025	19 Sep 2025	—
Dividend - Rs. - 2.0000	23 Sep 2024	—	—

Board meetings

13 Aug 2026 Board Meeting - Financial Results